Abstract
No public abstract is available from the verified source records.
Shang‐Ju Wu, Chien‐Yuan Chen, Ih‐Jen Su, Jih‐Luh Tang, Wen‐Chien Chou, Bo-Sheng Ko, Sheng-Yi Huang, Ming Yao, Woei Tsay, Yee‐Chun Chen, Chiu‐Hwa Wang, Hwei‐Fang Tien
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease
10.1200/jco.1999.17.3.776 · 1999
Clinical presentation and treatment of lymphocyte predominant Hodgkin's disease
1999
Neighborhood socioeconomic status and Hodgkin's lymphoma incidence in California
10.1158/1055-9965.epi-04-0567 · 2005
Hodgkin's disease in Asians. Incidence patterns and risk factors in population-based data
10.1016/s0145-2126(01)00126-6 · 2002
Geographic variation of Hodgkin's disease in Japan
1981
The pathology and nomenclature of Hodgkin's disease
1966
Staging for Hodgkin's disease
1990
Late results of the treatment of advanced Hodgkin's disease by the MOPP/COPP programs (chlormethine or cyclophosphamide, vincristine, procarbazine and pred-nisone)
1991
Combined cyclophosphamide, vincristine, procarbazine, and pred-nisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients
10.1002/1097-0142(197510)36:4<1241::aid-cncr2820360409>3.0.co;2-5 · 1975
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
openalex
Confidence 95%
datacite
Confidence 0%
Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience
10.1093/annonc/2.suppl_1.9 · 1991
Chemotherapy of Hodgkin's lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study Group
10.1007/bf02985239 · 1989
BEACOPP and COPP/ABVD as salvage treatment after primary extended field radiation therapy of early stage Hodgkin's disease—results of the German Hodgkin Study Group
10.1080/10428190500178167 · 2005
A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease
10.1056/nejm199811193392104 · 1998
The epidemiology of Hodgkin's disease
1999
Hodgkin's disease in Hong Kong Chinese
10.1002/hon.2900070602 · 1989
Hodgkin's disease in the Philippines
1996
The association between Epstein-Barr virus and Chinese Hodgkin's disease
10.1002/ijc.2910550303 · 1993
Hodgkin's lymphoma in Chinese migrants to British Columbia: a 25-year survey
10.1093/annonc/mdh132 · 2004
Classical Hodgkin's lym-phoma
2001
Non-Hodgkin's lymphomas in Asia
10.1016/s0889-8588(18)30396-4 · 1991
Chromosomal abnormalities of 200 Chinese patients with non-Hodgkin's lymphoma in Taiwan: with special reference to T-cell lymphoma
10.1093/annonc/mdh263 · 2004
Part I: Hodgkin's lymphoma—molecular biology of Hodgkin and Reed-Sternberg cells
10.1016/s1470-2045(03)01319-6 · 2004
Part II. Hodgkin's lymphoma—diagnosis and treatment
10.1016/s1470-2045(03)01320-2 · 2004
Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications
10.1200/jco.2005.02.9850 · 2006
Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation
10.1200/jco.2006.05.6879 · 2006
Salvage Therapy in Hodgkin's Lymphoma
10.1634/theoncologist.12-2-156 · 2007
Stem cell transplantation in Hodgkin's lymphoma
10.1586/14737140.7.3.297 · 2007
The role of allogeneic stem-cell transplantation in Hodgkin's disease
10.1111/j.1600-0609.2005.00469.x · 2005
Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed Hodgkin's lymphoma: results of a Spanish prospective cooperative protocol
10.1016/j.bbmt.2005.09.009 · 2006
Reduced intensity conditioning for allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: where do we stand?
10.1016/j.bbmt.2006.03.013 · 2006
Myocardial infarction mortality risk after treatment for Hodgkin's disease: a collaborative British cohort study
10.1093/jnci/djk029 · 2007
Hodgkin's disease: prognostic factors and treatment strategies
10.1097/00001622-200009000-00004 · 2000
No additional external references are available.